½ÃÀ庸°í¼­
»óǰÄÚµå
1447137

ôÃßÈıüºÇü¼ú ½ÃÀå ¿¹Ãø(-2030³â) : ¼ö¼ú À¯Çüº°, Àç·áº°, ôÃß»À À§Ä¡º°, ±â¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¼¼°è ºÐ¼®

Spinal Laminoplasty Market Forecasts to 2030 - Global Analysis By Surgery Type, By Material (Polyetheretherketone Implants, Titanium Implants and Tantalum Implants), Vertebral Position, Technology, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é, ôÃßÈıüºÇü¼ú ¼¼°è ½ÃÀåÀº 2023³â 59¾ï 8,000¸¸ ´Þ·¯·Î ¿¹Ãø ±â°£ µ¿¾È CAGR 5.5%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 87¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ôÃß Ã´ÃßÈıüºÇü¼úÀº ôÃß°üÀ» È®ÀåÇÏ¿© °æÃß Ã´Ãß°ü ÇùÂøÁõÀ» Ä¡·áÇÏ´Â µ¥ »ç¿ëµÇ´Â ¼ö¼úÀÔ´Ï´Ù. ôÃß°ü È®Àå¼úÀº ôÃß»ÀÀÇ ÇÑÂÊ¿¡ °æÃ¸À» ¸¸µé¾î µé¾î¿Ã·Á ô¼ö¿Í ½Å°æÀ» °¨¾ÐÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ÀÌ ¹æ¹ýÀº ô¼öÀÇ ¾ÈÁ¤¼ºÀ» À¯ÁöÇϸ鼭 ô¼ö ¾Ð¹ÚÀ¸·Î ÀÎÇÑ ÅëÁõ, ¸¶ºñ, ¼è¾à°¨ µîÀÇ Áõ»óÀ» ¿ÏÈ­ÇÕ´Ï´Ù.

2021³â¿¡ ¹ßÇ¥µÈ ¿¬±¸¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­ ¾à 50¸¸ °ÇÀÇ ¿äÃß ¼ö¼úÀÌ ÀÌ·ç¾îÁ³´Ù°í ÇÕ´Ï´Ù.

ôÃß°ü ÇùÂøÁõ À¯º´·ü »ó½Â

ôÃß°ü ÇùÂøÁõ À¯º´·üÀÇ Áõ°¡´Â ôÃßÈıüºÇü¼ú ½ÃÀåÀÇ Áß¿äÇÑ ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ôÃß°ü ÇùÂøÁõÀº ôÃß°üÀÌ Á¼¾ÆÁ® ô¼ö¿Í ½Å°æÀ» ¾Ð¹ÚÇÏ¿© ÅëÁõ, ¹«°¨°¢, ¼è¾à µîÀÇ Áõ»óÀ» À¯¹ßÇÏ´Â ÁúȯÀÔ´Ï´Ù. ô¼ö ¾Ð¹ÚÀ» ¿ÏÈ­Çϱâ À§ÇÑ ¼ö¼úÀΠôÃßÈıüºÇü¼úÀº ôÃß°ü ÇùÂøÁõ ȯÀÚÀÇ Ä¡·á ¿É¼ÇÀ¸·Î Á¡Á¡ ´õ ¸¹ÀÌ Ã¤Åõǰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¯ÀÚ ¼öÀÇ Áõ°¡´Â Ãß°£ÆÇ ¼ºÇü¼ú ¹× °ü·Ã ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÏ°í ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

°í°¡ÀÇ ½Ã¼ú ºñ¿ë

ȯÀÚµéÀº ƯÈ÷ ÀÇ·á º¸ÇèÀÌ Á¦ÇÑÀûÀ̰ųª º»ÀÎ ºÎ´ã±ÝÀÌ ³ôÀº Áö¿ª¿¡¼­ Ä¡·á¸¦ ¹ÞÀ» ¶§ °æÁ¦Àû À庮¿¡ Á÷¸éÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ¼­ºñ½º Á¦°øÀÚ ¹× ÀÇ·á±â°üÀº ÁöºÒÀÚ¿ÍÀÇ »óȯ ¹× °¡°Ý Çù»ó¿¡¼­ ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖÀ¸¸ç, ÀÌ´Â Àú·ÅÇÑ ¼­ºñ½º¸¦ Á¦°øÇÏ´Â ´É·Â¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºñ¿ë À庮Àº ȯÀÚµéÀÌ Ä¡·á¸¦ ¹Þ°Å³ª Ä¡·á¸¦ ¿Ï·áÇÏ´Â °ÍÀ» ÁÖÀúÇÏ°Ô ¸¸µé°í, ôÃßÈıüºÇü¼úÀÇ Àü¹ÝÀûÀÎ ½ÃÀå ÀáÀç·ÂÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÃÖ¼Òħ½À¼ö¼ú¿¡ ´ëÇÑ ÀνÄÀÇ º¯È­

ÃÖ¼Òħ½À ¼ö¼úÀº ±âÁ¸ÀÇ °³º¹ ¼ö¼ú¿¡ ºñÇØ ¼ö¼ú ÈÄ ÅëÁõ °¨¼Ò, ÀÔ¿ø ±â°£ ´ÜÃà, ȸº¹ ½Ã°£ ´ÜÃà µîÀÇ ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÁ¡¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó, ôÃß±³Á¤¼úÀ» Æ÷ÇÔÇÑ ÃÖ¼Òħ½À ôÃß ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ¼ö¼ú ±â¼ú ¹× ½Ã¼úÀÇ Çõ½ÅÀ» ÃËÁøÇϰí, ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀÌ ÃÖ¼Òħ½ÀÀû Á¢±Ù¹ýÀ» äÅÃÇϰí ôÃßÈıüºÇü¼ú ½ÃÀå¿¡¼­ Á¦°øÇÏ´Â Á¦Ç°À» È®´ëÇϵµ·Ï À¯µµÇϰí ÀÖ½À´Ï´Ù.

ôÃßÈıüºÇü¼ú¿¡ µû¸¥ ÇÕº´Áõ

ôÃßÈıüºÇü¼ú°ú °ü·ÃµÈ ÇÕº´ÁõÀº ½ÃÀå¿¡ Å« À§ÇùÀÌ µÇ°í ÀÖ½À´Ï´Ù. ½Å°æ ¼Õ»ó, °¨¿°, ôÃß ºÒ¾ÈÁ¤¼º µî ÀÌ·¯ÇÑ ÇÕº´ÁõÀº ¼ö¼ú ÈÄ ÇÕº´Áõ°ú ȯÀÚ ºÒ¸¸Á·À¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àç¼ö¼ú°ú Àå±âÀûÀÎ ÇÕº´ÁõÀÇ À§ÇèÀº ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚ ¸ðµÎ Ä¡·á ¿É¼ÇÀ¸·Î ÃþÈ­¼úÀ» ¼±ÅÃÇÏ´Â °ÍÀ» ÁÖÀúÇÏ°Ô ¸¸µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÎÁ¤ÀûÀÎ °á°ú´Â ¼ö¼úÀÇ ¸í¼ºÀ» ÈѼÕÇϰí äÅ÷üÀ» °¨¼Ò½ÃÄÑ Ã´ÃßÈıüºÇü¼ú ½ÃÀåÀÇ ¼ºÀå Àü¸Á¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ:

COVID-19 Àü¿°º´Àº ¼±ÅÃÀû ¼ö¼úÀ» Áß´ÜÇϰí ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ È¯ÀÚÀÇ Á¢±Ù¼ºÀ» °¨¼Ò½ÃÅ´À¸·Î½á ôÃßÈıüºÇü¼ú ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ºÀ¼â Á¶Ä¡¿Í Àü¿°º´ °ü¸®¿¡ ´ëÇÑ ÀÚ¿ø ÀçºÐ¹è·Î ÀÎÇØ ±ä±ÞÇÏÁö ¾ÊÀº ôÃß ¼ö¼úÀÌ ¿¬±âµÇ¾ú½À´Ï´Ù. ±× °á°ú, ôÃßÈıüºÇü¼ú ¼­ºñ½º¸¦ Á¦°øÇÏ´Â ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ ¼ö¼ú °Ç¼ö¿Í ¼öÀÍÀÌ °¨¼ÒÇß½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È °³¹æÇü ôÃßÈıüºÇü¼ú ºÐ¾ß°¡ °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»ó

¿¹Ãø ±â°£ µ¿¾È ôÃßÈıüºÇü¼ú ½ÃÀåÀº °³º¹ ôÃßÈıüºÇü¼úÀÌ ÁÖ·ù¸¦ ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â °³º¹ ôÃßÈıüºÇü¼úÀÌ ¿À·£ ±â°£ µ¿¾È »ç¿ëµÇ¾î ¿Ô°í È®¸³µÈ ¼ö¼ú ±â¹ýÀ̱⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, °³º¹ ôÃßÈıüºÇü¼úÀº ÃÖ¼Ò Ä§½ÀÀû ±â¼ú¿¡ ºñÇØ ô¼ö °¡½ÃÈ­ ¹× °¨¾ÐÀÌ °¡´ÉÇÕ´Ï´Ù. ¶ÇÇÑ, ¿Ü°ú ÀÇ»çµéÀÌ Àͼ÷ÇÏ°í °ËÁõµÈ ¼ö¼ú ¹æ¹ýÀ» ¼±È£ÇÏ´Â °Íµµ ôÃß ¼ö¼ú¿¡¼­ °³º¹ ôÃßÈıüºÇü¼ú¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È 3D ÇÁ¸°ÆÃ ºÐ¾ß°¡ °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»ó

3D ÇÁ¸°ÆÃ ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È ôÃßÈıüºÇü¼ú ½ÃÀå¿¡¼­ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¿øµ¿·ÂÀº 3D ÇÁ¸°ÆÃ ±â¼úÀÇ ¹ßÀüÀ¸·Î °³º° ÇØºÎÇÐÀû ±¸Á¶¿¡ ¸Â´Â ȯÀÚ ¸ÂÃãÇü ÀÓÇöõÆ® ¹× ¼ö¼ú±â±¸¸¦ Á¦ÀÛÇÒ ¼ö ÀÖ°Ô µÇ¾ú±â ¶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, 3D ÇÁ¸°ÆÃÀº ¼ö¼ú Á¤È®µµ Çâ»ó, Á¦Á¶ ½Ã°£ ´ÜÃà, ºñ¿ë Àý°¨ µîÀÇ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ôÃßÈıüºÇü¼ú¿¡¼­ 3D ÇÁ¸°ÆÃÀÇ Ã¤Åà Ȯ´ë¿¡ ±â¿©ÇÏ¸ç ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÃÖ´ë ½ÃÀå Á¡À¯À² Áö¿ª

ºÏ¹Ì Áö¿ªÀº ¼±ÁøÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó, ³ôÀº ôÃß Áúȯ À¯º´·ü, Çõ½ÅÀûÀÎ ÀÇ·á ±â¼úÀÇ Á¶±â µµÀÔÀ¸·Î ÀÎÇØ ôÃß Ã´Ãß ±³Á¤¼ú ½ÃÀå¿¡¼­ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °­·ÂÇÑ »óȯ Á¤Ã¥°ú À¯¸®ÇÑ ÀÇ·á ±ÔÁ¦´Â ºÏ¹Ì¿¡¼­ ôÃß ¼ö¼úÀÇ º¸±ÞÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´ëÇü ÀÇ·á±â±â ±â¾÷ ¹× À¯¸í ÀÇ·á±â°üÀÇ Á¸Àç´Â ÀÌ Áö¿ªÀÇ Ã´Ãß Ã´Ãß±³Á¤¼ú ½ÃÀå¿¡¼­ÀÇ ¿ìÀ§¸¦ ´õ¿í °­È­½Ã۰í ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

¾Æ½Ã¾ÆÅÂÆò¾çÀº ôÃß ÁúȯÀÇ À¯º´·ü Áõ°¡, ÀÇ·áºñ Áõ°¡, °í±Þ ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë·Î ÀÎÇØ ôÃß Ã´Ãß ±³Á¤¼ú ½ÃÀåÀÌ ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±°ú ôÃß °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ôÃßÈıüºÇü¼ú°ú °°Àº ¿Ü°úÀû °³ÀÔ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ Àα¸°¡ ¸¹°í °í·ÉÈ­µÊ¿¡ µû¶ó ¸¹Àº ȯÀÚ°¡ Á¸ÀçÇϸç, ÀÌ´Â ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå¿¡¼­ ôÃß ¼ö¼úÀÇ ¼ºÀå ±âȸ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º:

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù:

  • ±â¾÷ °³¿ä
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®(ÃÖ´ë 3°³»ç)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤Ä¡, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º °ËÅä¿¡ µû¸¥)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù¹ý
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç ¼Ò½º
    • 2Â÷ Á¶»ç ¼Ò½º
    • °¡Á¤

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ±â¼ú ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ Ã´ÃßÈıüºÇü¼ú ½ÃÀå : ¼ö¼ú À¯Çüº°

  • ¿ÀÇ ÈıüºÇü¼ú
  • ÃÖ¼Òħ½À ÈıüºÇü¼ú
    • °æÇÇ ÈıüºÇü¼ú
    • ÃÖ¼Òħ½À ¿ÀÇ µµ¾î ÈıüºÇü¼ú
    • À¯´ÏÆ÷Å» ÈıüºÇü¼ú

Á¦6Àå ¼¼°èÀÇ Ã´ÃßÈıüºÇü¼ú ½ÃÀå : Àç·áº°

  • Æú¸®¿¡Å׸£¿¡Å׸£ÄÉÅæ(PEEK) ÀÓÇöõÆ®
  • ƼŸ´½ ÀÓÇöõÆ®
  • źŻ ÀÓÇöõÆ®

Á¦7Àå ¼¼°èÀÇ Ã´ÃßÈıüºÇü¼ú ½ÃÀå : ôÃß»À À§Ä¡º°

  • °æÃß ÈıüºÇü¼ú
  • ¿äÃß ÈıüºÇü¼ú
  • õ°ñ ÈıüºÇü¼ú
  • ÈäÃß ÈıüºÇü¼ú
  • ±âŸ

Á¦8Àå ôÃßÈıüºÇü¼ú ¼¼°è ½ÃÀå : ±â¼úº°

  • 3D ÇÁ¸°ÆÃ
  • »ý¹°ÇÐÀû Á¦Á¦
  • °í¼Ó µå¸±
  • ¼ö¼úÁß ½Å°æ ¸ð´ÏÅ͸µ
  • ·Îº¿°øÇÐ
  • ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ
  • ÃÊÀ½ÆÄ »À ¸Þ½º
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ Ã´ÃßÈıüºÇü¼ú ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Àü¹® Ŭ¸®´Ð

Á¦10Àå ¼¼°èÀÇ Ã´ÃßÈıüºÇü¼ú ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛÅõÀÚ
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ °³¿ä

  • Aesculap, Inc.
  • Alphatec Holdings, Inc.
  • Amedica Corporation
  • Captiva Spine
  • CoreLink, LLC
  • DePuy Synthes
  • Globus Medical Inc.
  • Joimax GmbH
  • Medtronic plc
  • Nexxt Spine LLC
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Osseus Fusion Systems
  • RTI Surgical Holdings, Inc.
  • Spinal Elements, Inc.
  • Spineart
  • Stryker Corporation
  • Ulrich Medical
  • Zimmer Biomet Holdings, Inc.
ksm 24.04.24

According to Stratistics MRC, the Global Spinal Laminoplasty Market is accounted for $5.98 billion in 2023 and is expected to reach $8.71 billion by 2030 growing at a CAGR of 5.5% during the forecast period. Spinal laminoplasty is a surgical procedure used to treat cervical spinal stenosis by enlarging the spinal canal. It involves creating a hinge on one side of the lamina bone and lifting it, allowing decompression of the spinal cord and nerves. This technique preserves spinal stability while providing relief from symptoms such as pain, numbness, and weakness caused by spinal cord compression.

According to a study published in 2021, approximately 500,000 lumbar spine surgeries were performed in the US.

Market Dynamics:

Driver:

Rising prevalence of spinal stenosis

The rising prevalence of spinal stenosis serves as a significant driver in the spinal laminoplasty market. Spinal stenosis, characterized by the narrowing of the spinal canal, leads to compression of the spinal cord and nerves, causing symptoms like pain, numbness, and weakness. Spinal laminoplasty, a surgical procedure aimed at alleviating spinal cord compression, is increasingly adopted as a treatment option for patients with spinal stenosis. This growing patient population drives demand for laminoplasty procedures and related medical devices, fostering market growth.

Restraint:

High cost of procedures

Patients may face financial barriers to accessing treatment, especially in regions with limited healthcare coverage or high out-of-pocket expenses. Additionally, healthcare providers and facilities may experience challenges in reimbursement and pricing negotiations with payers, impacting their ability to offer affordable services. This cost barrier can deter patients from seeking or completing treatment, thereby limiting the overall market potential for spinal laminoplasty procedures.

Opportunity:

Growing awareness of minimally invasive surgeries

Minimally invasive techniques offer advantages such as reduced post-operative pain, shorter hospital stays, and quicker recovery times compared to traditional open surgeries. As patients become more informed about these benefits, there is a rising demand for minimally invasive spinal procedures, including laminoplasty. This trend drives innovation in surgical technologies and techniques, encouraging healthcare providers to adopt minimally invasive approaches and expand their offerings in the spinal laminoplasty market.

Threat:

Complications associated with spinal laminoplasty

The complications associated with spinal laminoplasty pose a significant threat to the market. These complications, including nerve damage, infection, and instability of the spine, can lead to post-operative complications and patient dissatisfaction. Moreover, the risk of reoperation and long-term complications may deter both patients and healthcare providers from choosing laminoplasty as a treatment option. Additionally, negative outcomes can damage the reputation of the procedure and decrease its adoption rate, impacting the growth prospects of the spinal laminoplasty market.

Covid-19 Impact:

The COVID-19 pandemic has impacted the spinal laminoplasty market by disrupting elective surgeries and reducing patient access to healthcare facilities. Lockdown measures and reallocation of resources towards managing the pandemic led to the postponement of non-urgent spinal procedures. This resulted in decreased procedural volumes and revenue for healthcare providers offering spinal laminoplasty services.

The open laminoplasty segment is expected to be the largest during the forecast period

Over the forecast period, the open laminoplasty segment is anticipated to dominate the spinal laminoplasty market. This is attributed to the long-standing use of and established surgical techniques associated with open laminoplasty procedures. Additionally, open laminoplasty allows for greater visualization and decompression of the spinal cord compared to minimally invasive techniques. Furthermore, the preference for familiar and proven surgical methods by surgeons contributes to the sustained demand for open laminoplasty procedures in spinal surgery.

The 3D printing segment is expected to have the highest CAGR during the forecast period

The 3D printing segment is projected to witness the highest growth rate in the spinal laminoplasty market during the forecast period. This growth is driven by advancements in 3D printing technology, enabling the production of patient-specific implants and surgical instruments tailored to individual anatomies. Additionally, 3D printing offers benefits such as improved surgical precision, faster production times, and reduced costs. These factors contribute to the increasing adoption of 3D printing in spinal laminoplasty procedures, fueling market growth.

Region with largest share:

North America is positioned to secure the largest market share in the spinal laminoplasty market due to the region's advanced healthcare infrastructure, high prevalence of spinal disorders, and early adoption of innovative medical technologies. Additionally, robust reimbursement policies and favorable healthcare regulations support the uptake of spinal procedures in North America. Moreover, the presence of leading medical device companies and renowned healthcare institutions further strengthens the region's dominance in the spinal laminoplasty market.

Region with highest CAGR:

The Asia-Pacific region is poised for rapid growth in the spinal laminoplasty market owing to the increasing prevalence of spinal disorders, rising healthcare expenditures, and expanding access to advanced medical facilities. Additionally, improving healthcare infrastructure and growing awareness about spinal health drive demand for surgical interventions like laminoplasty. Moreover, the region's large population and aging demographics create a substantial patient pool, contributing to the growth opportunities for spinal procedures in the Asia-Pacific market.

Key players in the market

Some of the key players in Spinal Laminoplasty Market include Aesculap, Inc., Alphatec Holdings, Inc., Amedica Corporation, Captiva Spine, CoreLink, LLC, DePuy Synthes, Globus Medical Inc., Joimax GmbH, Medtronic plc, Nexxt Spine LLC, NuVasive, Inc., Orthofix Medical Inc., Osseus Fusion Systems, RTI Surgical Holdings, Inc., Spinal Elements, Inc., Spineart, Stryker Corporation, Ulrich Medical and Zimmer Biomet Holdings, Inc.

Key Developments:

In October 2023, Johnson & Johnson MedTech announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its TriLEAP(TM) Lower Extremity Anatomic Plating System, a comprehensive yet modular, procedure-specific system designed to meet the complex needs of orthopaedic surgeons, doctors of podiatric medicine, and foot and ankle specialists. The TriLEAP(TM) System provides a diverse offering of contoured and conventional plates that can accommodate multiple screw diameters, and instruments that can be used during the reduction, internal fixation and fusion of bones and bone fragments.

In September 2023, Globus Medical, Inc., a leading musculoskeletal solutions company, today announced it has completed its previously announced merger with NuVasive, Inc. The combined company will provide surgeons and patients with one of the most comprehensive offerings of musculoskeletal procedural solutions and enabling technologies to impact the care continuum.

In December 2022, Captiva Spine announces an exclusive strategic partnership with REMEX Medical for Spine Navigation and Robotics, adding to their expanding product portfolio. For underserved hospitals and Ambulatory Surgery Centers (ASCs) throughout the U.S., this technology will serve as a platform to expand the company's products and services with enhanced enabling technology to support MIS technology. Specifically, Captiva Spine will be starting with their CapLOX Pedicle Screws, TowerLOX-EXT MIS Extended Tab Pedicle Screws, and TransFasten Posterior SI joint fusion system.

Survey Types Covered:

  • Open Laminoplasty
  • Minimally Invasive Laminoplasty

Materials Covered:

  • Polyetheretherketone (PEEK) Implants
  • Titanium Implants
  • Tantalum Implants

Vertebral Positions Covered:

  • Cervical Laminoplasty
  • Lumbar Laminoplasty
  • Sacral Laminoplasty
  • Thoracic Laminoplasty
  • Other Vertebral Positions

Technologies Covered:

  • 3D Printing
  • Biologics
  • High-Speed Drills
  • Intraoperative Neuromonitoring
  • Robotics
  • Surgical Navigation Systems
  • Ultrasonic Bone Scalpel
  • Other Technologies

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Spinal Laminoplasty Market, By Surgery Type

  • 5.1 Introduction
  • 5.2 Open Laminoplasty
  • 5.3 Minimally Invasive Laminoplasty
    • 5.3.1 Percutaneous Laminoplasty
    • 5.3.2 Minimally Invasive Open Door Laminoplasty
    • 5.3.3 Uniportal Laminoplasty

6 Global Spinal Laminoplasty Market, By Material

  • 6.1 Introduction
  • 6.2 Polyetheretherketone (PEEK) Implants
  • 6.3 Titanium Implants
  • 6.4 Tantalum Implants

7 Global Spinal Laminoplasty Market, By Vertebral Position

  • 7.1 Introduction
  • 7.2 Cervical Laminoplasty
  • 7.3 Lumbar Laminoplasty
  • 7.4 Sacral Laminoplasty
  • 7.5 Thoracic Laminoplasty
  • 7.6 Other Vertebral Positions

8 Global Spinal Laminoplasty Market, By Technology

  • 8.1 Introduction
  • 8.2 3D Printing
  • 8.3 Biologics
  • 8.4 High-Speed Drills
  • 8.5 Intraoperative Neuromonitoring
  • 8.6 Robotics
  • 8.7 Surgical Navigation Systems
  • 8.8 Ultrasonic Bone Scalpel
  • 8.9 Other Technologies

9 Global Spinal Laminoplasty Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Ambulatory Surgical Centers
  • 9.4 Specialty Clinics

10 Global Spinal Laminoplasty Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Aesculap, Inc.
  • 12.2 Alphatec Holdings, Inc.
  • 12.3 Amedica Corporation
  • 12.4 Captiva Spine
  • 12.5 CoreLink, LLC
  • 12.6 DePuy Synthes
  • 12.7 Globus Medical Inc.
  • 12.8 Joimax GmbH
  • 12.9 Medtronic plc
  • 12.10 Nexxt Spine LLC
  • 12.11 NuVasive, Inc.
  • 12.12 Orthofix Medical Inc.
  • 12.13 Osseus Fusion Systems
  • 12.14 RTI Surgical Holdings, Inc.
  • 12.15 Spinal Elements, Inc.
  • 12.16 Spineart
  • 12.17 Stryker Corporation
  • 12.18 Ulrich Medical
  • 12.19 Zimmer Biomet Holdings, Inc.
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦